Verastem Oncology Announces Fourth Quarter and Full-Year 2018 Financial Results and Corporate Developments

Go back to Verastem Oncology Announces Fourth Quarter and Full-Year 2018 Financial Results and Corporate Developments
VERASTEM SHS (NASDAQ: VSTM) Delayed: 8.37 +0.38 (4.76%)
Previous Close $7.99    52 Week High $2.43 
Open $8.04    52 Week Low $1.05 
Day High $8.65    P/E N/A 
Day Low $8.00    EPS $-1.79 
Volume 3,056,454